Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETR/VIA stock hub

ETR/VIA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/VIAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
17B
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/VIA
In the news

Latest news · ETR/VIA

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.8
P25 12.3P50 15.7P75 20.2
Trailing P/En/a
P25 16.4P50 20.9P75 30.4
ROE-2
P25 -6.7P50 8.5P75 17.2
ROIC5.1
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/VIA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
208
Groups with data
11
Currency
USD
Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
DE
Employees
30,000
Employees Change
-2,000%
Employees Change Percent
-6.25
Enterprise value
EUR 27.4B
Exchange
Deutsche Börse Xetra
Financial currency
USD
First seen
2026-05-10
Industry
 Drug Manufacturers - Specialty & Generic
Isin
US92556V1061
Last refreshed
2026-05-10
Market cap
EUR 17B
Price
EUR 14.32
Price currency
EUR
Rev Per Employee
421,004.77x
Sector
Healthcare
Sic
2834
Symbol
etr/VIA
Website
https://www.viatris.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
-1.51%
EV Earnings
-106.4x
EV/EBIT
23.18x
EV/EBITDA
7.64x
EV/FCF
17.6x
EV/Sales
2.21x
FCF yield
9.15%
Forward P/E
6.81x
P/B ratio
1.34x
P/S ratio
1.35x
PE Ratio10 Y
82.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
9.54%
EBITDA Margin
28.33%
FCF margin
12.31%
Gross margin
39.82%
Gross Profit
EUR 5B
Gross Profit Growth
-0.43%
Gross Profit Growth Q
11.58%
Gross Profit Growth3 Y
-5.15%
Gross Profit Growth5 Y
1.41%
Net Income
EUR -257.2M
Pretax Margin
-5.6%
Profit Margin
-2.04%
Profit Per Employee
EUR -8,572
ROA
2.31
Roa5y
2.25
ROCE
4.63
ROE
-1.96
Roe5y
-3.98
ROIC
5.07
Roic5y
3.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr1y
100.56%
Cagr3y
25.74%
Cagr5y
9.4%
Div CAGR3
-3.52%
FCF Growth
-5.9%
FCF Growth Q
-29.32%
FCF Growth3 Y
-9.22%
FCF Growth5 Y
3.08%
OCF Growth
-2.48%
OCF Growth Q
-27.49%
OCF Growth10 Y
1.76%
OCF Growth3 Y
-8%
OCF Growth5 Y
3.92%
Revenue Growth
1.62x
Revenue Growth Q
8.07x
Revenue Growth3 Y
-2.68x
Revenue Growth5 Y
1.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.39
Assets
EUR 31.9B
Cash
EUR 2.1B
Current Assets
EUR 9.3B
Current Liabilities
EUR 5.8B
Debt
EUR 12.7B
Debt EBITDA
EUR 3.46
Debt Equity
EUR 1
Debt FCF
EUR 8.15
Equity
EUR 12.7B
Interest Coverage
2.92
Liabilities
EUR 19.2B
Long Term Assets
EUR 22.7B
Long Term Liabilities
EUR 13.5B
Net Cash
EUR -10.6B
Net Cash By Market Cap
EUR -62.34
Net Debt EBITDA
EUR 2.96
Net Debt Equity
EUR 0.83
Net Debt FCF
EUR 6.81
Tangible Book Value
EUR -5.7B
Tangible Book Value Per Share
EUR -4.85
WACC
7.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.6
Inventory Turnover
2.18
Net Working Capital
EUR 3.2B
Quick ratio
0.9
Working Capital
EUR 3.6B
Working Capital Turnover
EUR 3.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
2.61%
Dividend Growth
-5.91%
Dividend Growth Years
0%
Dividend per share
EUR 0.42
Dividend Years
6
Dividend Yield
2.86%
Ex Div Date
2026-03-09
Last Dividend
EUR 0.1
Payout Frequency
Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
100.47%
200-day SMA
10.29
3Y total return
98.82%
50-day SMA
12.28
50-day SMA vs 200-day SMA
50over200
5Y total return
56.7%
All Time High
15.7
All Time High Change
-7.03%
All Time High Date
2021-02-15
All Time Low
6.28
All Time Low Change
132.35%
All Time Low Date
2025-04-10
ATR
0.48
Beta
1.16
Ch YTD
38.48
High
14.86
High52
14.86
High52 Date
2026-05-08
High52ch
-3.63%
Low
14.32
Low52
7.27
Low52 Date
2025-05-23
Low52ch
97%
Ma50ch
18.88%
Price vs 200-day SMA
41.83%
RSI
83.64
RSI Monthly
66.52
RSI Weekly
74.31
Sharpe ratio
2.13x
Sortino ratio
3.96
Total Return
5.47%
Tr YTD
39.66
Tr1m
27.32%
Tr1w
12.07%
Tr3m
20.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 1.2B
Operating Income Growth
10.41
Operating Income Growth Q
187.5
Operating Income Growth3 Y
-17.95
Operating Income Growth5 Y
3.78
Operating margin
9.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
1,154,493,916%
Net Borrowing
-1,102,350.6
Shares Insiders
0.7%
Shares Institutions
86.04%
Shares Qo Q
1.97%
Shares Yo Y
-2.61%
Short Ratio
3.11

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
EUR 1.4B
Average Volume
2,764.7x
Bv Per Share
10.92
CAPEX
EUR -326.2M
Ch1m
27.32
Ch1w
12.07
Ch1y
91.5
Ch3m
19.69
Ch3y
73.78
Ch5y
27.03
Ch6m
67.89
Change
1.63%
Change From Open
-3.31
Close
14.09
Days Gap
5.11
Depreciation Amortization
2,319,854,439.6
Dollar Volume
169,095.6
Earnings Date
2026-05-07
EBIT
EUR 1.2B
EBITDA
EUR 3.6B
EPS
EUR -0.22
F Score
5
FCF
EUR 1.6B
FCF EV Yield
5.68x
Financing CF
-893,926,110
Fiscal Year End
December
Founded
1,961
Goodwill
5,674,900,888.8
Income Tax
EUR -450M
Investing CF
-73,893,960
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
10.9
Ma150ch
33.96%
Ma20
12.62
Ma20ch
15.67%
Net CF
910,144,620
Next Earnings Date
2026-08-07
Open
14.81
P FCF Ratio
10.93
P OCF Ratio
9.03
Payment Date
2026-03-18
Position In Range
0
Ppne
2,358,097,525.8
Price Date
2026-05-08
Price EBITDA
EUR 4.75
Relative Volume
4.27x
Revenue
12,630,142,980x
SBC By Revenue
1.17x
Share Based Comp
148,048,110
Tax By Revenue
-3.56x
Tr6m
71.29%
Volume
11,810
Z Score
0.98
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

ETR/VIA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.9%
$0.42 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
+5.5%
Next ex-dividend date: 2026-03-09
Performance

ETR/VIA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+100.5%
S&P 500 1Y: n/a
3Y total return
+98.8%
S&P 500 3Y: n/a
5Y total return
+56.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns ETR/VIA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+86.0%
Share of float held by funds and institutions
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.1 days to cover
Y/Y dilution
-2.6%
Negative means the company is buying back shares.
Technical

ETR/VIA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
83.6
Above 70: short-term overbought
Price vs 200-day MA
+41.8%
50/200-day relationship not available
Beta (5Y)
1.16
Moves roughly with the market
Sharpe ratio
2.13
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/VIA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/VIA stock rating?

etr/VIA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/VIA analysis?

The full report lives at /stocks/etr/VIA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/VIA?

The latest report frames etr/VIA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/VIA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.